These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6890635)

  • 1. Effects of naloxone on d-amphetamine- and apomorphine-induced behavior.
    Hitzemann R; Curell J; Hom D; Loh H
    Neuropharmacology; 1982 Oct; 21(10):1005-11. PubMed ID: 6890635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain locations controlling the behavioral effects of chronic amphetamine intoxication.
    Hitzemann R; Wu J; Hom D; Loh H
    Psychopharmacology (Berl); 1980; 72(1):93-101. PubMed ID: 6162168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotyped behavior and diabetes mellitus in rats: reduced behavioral effects of amphetamine and apomorphine and reduced in vivo brain binding of [3H]spiroperidol.
    Rowland N; Joyce JN; Bellush LL
    Behav Neurosci; 1985 Oct; 99(5):831-41. PubMed ID: 3916385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs.
    Feigenbaum J; Yanai J; Moon B; Klawans H
    Neuropharmacology; 1983 Dec; 22(12A):1369-76. PubMed ID: 6686653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term d-amphetamine in rats: lack of change in post-synaptic dopamine receptor sensitivity.
    Jackson DM; Bailey RC; Christie MJ; Crisp CA; Skerritt JH
    Psychopharmacology (Berl); 1981; 73(3):276-80. PubMed ID: 6787649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
    Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ
    Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry.
    Jones GH; Hernandez TD; Kendall DA; Marsden CA; Robbins TW
    Pharmacol Biochem Behav; 1992 Sep; 43(1):17-35. PubMed ID: 1384071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of estrogen and progesterone on behavioral effects of apomorphine and amphetamine.
    Michanek A; Meyerson BJ
    Pharmacol Biochem Behav; 1982 Jun; 16(6):875-9. PubMed ID: 7202216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of naloxone on dopamine uptake and release in vitro in the striatum.
    Feigenbaum JJ; Yanai J; Iser C; Klawans H
    Neuropsychobiology; 1984; 11(2):94-7. PubMed ID: 6483167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amantadine and L-dopa on apomorphine- and d-amphetamine-induced stereotyped behaviour in rats.
    Cox B; Tha SJ
    Eur J Pharmacol; 1973 Oct; 24(1):96-100. PubMed ID: 4796449
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    J Neurochem; 1992 Jun; 58(6):2285-91. PubMed ID: 1349347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the behavioral effects of d-amphetamine and apomorphine in the rat.
    Antoniou K; Kafetzopoulos E
    Pharmacol Biochem Behav; 1991 May; 39(1):61-70. PubMed ID: 1924514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of apomorphine and D-amphetamine effects by naloxone.
    Adams PM; Beauchamp R; Alston C
    Life Sci; 1981 Feb; 28(6):629-34. PubMed ID: 7193793
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone.
    Conway P; Uretsky NJ
    Neuropharmacology; 1983 May; 22(5):579-86. PubMed ID: 6308493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of amphetamine and apomorphine after striatal lesions in the rat.
    Antoniou K; Kafetzopoulos E
    Pharmacol Biochem Behav; 1992 Nov; 43(3):705-22. PubMed ID: 1448467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.